Related Experiment Video

Updated: May 28, 2026

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

Chronic management and health supervision of individuals with propionic acidemia

V Reid Sutton1, Kimberly A Chapman, Andrea L Gropman

  • 1Department of Molecular & Human Genetics, Baylor College of Medicine & Texas Children's Hospital, Houston, TX, USA. vrsutton@texaschildrens.org

Molecular Genetics and Metabolism
|October 4, 2011
PubMed

Insights

Propionic acidemia, a rare metabolic disorder, presents serious health risks. New guidelines offer comprehensive chronic management strategies for patients, improving care for this inborn error of metabolism.

Area of Science:

  • Biochemistry
  • Genetics
  • Pediatrics

Background:

  • Propionic acidemia is a rare inborn error of metabolism.
  • Patients face life-threatening hyperammonemia, metabolic acidosis, and intellectual disability.
  • Other complications include poor growth, seizures, and cardiomyopathy, with limited incidence data.

Purpose of the Study:

  • To develop practice guidelines for the chronic management of propionic acidemia.
  • To address the lack of clear medical and surgical management guidelines.
  • To consolidate expert opinion and literature for improved patient care.

Main Methods:

  • Systematic review of current medical literature.
  • Survey of expert opinion on propionic acidemia management.
  • Development of evidence-based practice guidelines.

Main Results:

  • Established guidelines for chronic management of propionic acidemia.
  • Guidelines cover dietary therapy, medications, and laboratory monitoring.
  • Recommendations include chronic health supervision, gastrostomy tubes, and liver transplantation.

Conclusions:

  • The developed guidelines provide a framework for managing propionic acidemia.
  • These guidelines aim to improve long-term health outcomes for affected individuals.
  • Standardized management is crucial for this rare metabolic disorder.

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...